MARKET

ANIP

ANIP

ANI Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

31.88
-0.46
-1.42%
Closed 16:00 07/01 EDT
OPEN
32.35
PREV CLOSE
32.34
HIGH
32.89
LOW
31.57
VOLUME
96.98K
TURNOVER
--
52 WEEK HIGH
86.96
52 WEEK LOW
28.28
MARKET CAP
393.42M
P/E (TTM)
-221.3889
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ANIP stock price target is 45.67 with a high estimate of 49.00 and a low estimate of 40.00.

EPS

ANIP News

More
ANI Pharmaceuticals Announces Launch Of Mexiletine Hydrochloride Capsules
BAUDETTE, Minn., June 30, 2020 /PRNewswire/ --ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ:ANIP) today announced the launch of Mexiletine Hydrochloride Capsules USP, 150mg, 200mg and 250mg. The current
Benzinga · 1d ago
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq:ANIP) today announced the launch of Mexiletine Hydrochloride Capsules USP, 150mg, 200mg and 250mg. The current annual U.S. market for this product is approximately $16 million, according to IQVIA/IMS Health.
PR Newswire · 1d ago
ANI Pharmaceuticals: Significantly Undervalued
Seeking Alpha - Article · 2d ago
Edited Transcript of ANIP.OQ earnings conference call or presentation 7-May-20 2:30pm GMT
Q1 2020 ANI Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents · 06/15 03:38
Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical Stocks
MotleyFool.com · 06/03 10:32
ANI Pharmaceuticals Provides Update on Recent Regulatory Filing
PR Newswire · 06/01 13:30
Earnings Release: Here's Why Analysts Cut Their ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Price Target To US$45.67
Simply Wall St. · 05/09 13:21
ANI Pharmaceuticals, Inc. (ANIP) CEO Arthur Przybyl on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/09 09:00

Industry

Biotechnology & Medical Research
-0.33%
Pharmaceuticals & Medical Research
+0.20%

Hot Stocks

Symbol
Price
%Change

About ANIP

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It also performs contract manufacturing for other pharmaceutical companies. Its products include both branded and generic pharmaceuticals. Its generic products include Erythromycin Ethylsuccinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Nimodipine, Opium Tincture, Oxycodone Capsules, Oxycodone Oral Solution, Propafenone and Vancomycin. Its branded products include Cortenema, Inderal LA, Lithobid, Reglan and Vancocin. Its pharmaceutical manufacturing facilities are located in Baudette, Minnesota.
More

Webull offers kinds of ANI Pharmaceuticals Inc stock information, including NASDAQ:ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.